Additionally, it is also suggested in 2017 that CD8+PD-1+Tim-3+Lag-3+ tumor-infiltrating lymphocytes, ICOS+ tumor-infiltrating Treg cells may be as significant factors for postoperative early relapse in localized RCC patients10. This evidence concerns the gene LAG3 and neoplasm.